U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
divozilimab [INN]
Preferred Name English
DIVOZILIMAB
INN  
Official Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 ANTIGEN) (HUMAN-MUS MUSCULUS MONOCLONAL BCD-132 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL BCD-132 .KAPPA.-CHAIN, DIMER
Common Name English
Divozilimab [WHO-DD]
Common Name English
Code System Code Type Description
FDA UNII
13ZEQ1M5ML
Created by admin on Wed Apr 02 08:25:49 GMT 2025 , Edited by admin on Wed Apr 02 08:25:49 GMT 2025
PRIMARY
CAS
2254061-60-2
Created by admin on Wed Apr 02 08:25:49 GMT 2025 , Edited by admin on Wed Apr 02 08:25:49 GMT 2025
PRIMARY
NCI_THESAURUS
C175772
Created by admin on Wed Apr 02 08:25:49 GMT 2025 , Edited by admin on Wed Apr 02 08:25:49 GMT 2025
PRIMARY
INN
11336
Created by admin on Wed Apr 02 08:25:49 GMT 2025 , Edited by admin on Wed Apr 02 08:25:49 GMT 2025
PRIMARY
SMS_ID
300000028812
Created by admin on Wed Apr 02 08:25:49 GMT 2025 , Edited by admin on Wed Apr 02 08:25:49 GMT 2025
PRIMARY
ACTIVE MOIETY
DIVOZILIMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966